🇺🇸 FDA
Patent

US 9610331

Methods for hematopoietic precursor mobilization

granted A61KA61K31/4439A61K31/727

Quick answer

US patent 9610331 (Methods for hematopoietic precursor mobilization) held by TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
Grant date
Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/4439, A61K31/727, A61K38/1816, A61K38/363